These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33617311)

  • 1. Screening for Fabry Disease in Male Patients With Arrhythmia Requiring a Pacemaker or an Implantable Cardioverter-Defibrillator.
    Hemelsoet D; De Keyser J; Van Heuverswyn F; Willems R; Vandekerckhove H; Bondue A; de Asmundis C; Saenen J; Van de Walle S; Godart P; Kampmann C; Stepman H; Poppe B; Terryn W
    Circulation; 2021 Feb; 143(8):872-874. PubMed ID: 33617311
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.
    Weidemann F; Maier SK; Störk S; Brunner T; Liu D; Hu K; Seydelmann N; Schneider A; Becher J; Canan-Kühl S; Blaschke D; Bijnens B; Ertl G; Wanner C; Nordbeck P
    Am J Cardiol; 2016 Jul; 118(2):264-74. PubMed ID: 27265676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy.
    Vijapurapu R; Geberhiwot T; Jovanovic A; Baig S; Nordin S; Kozor R; Leyva F; Kotecha D; Wheeldon N; Deegan P; Rusk RA; Moon JC; Hughes DA; Woolfson P; Steeds RP
    Heart; 2019 Dec; 105(23):1825-1831. PubMed ID: 31446426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry Disease with Pacemaker Implantation as the Initial Event.
    Kato Y; Ishikawa A; Aoki S; Sato H; Ojima Y; Kagaya S; Nagasawa T
    Intern Med; 2019 Oct; 58(20):2993-3000. PubMed ID: 31243236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular Tachycardia in Fabry Disease Detected in a 50-Year-Old Woman during 14-Day Continuous Cardiac Monitoring.
    Silva-Gburek J; Rochford L; Hopkin R; Jefferies JL
    Tex Heart Inst J; 2016 Dec; 43(6):531-533. PubMed ID: 28100976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should unipolar pacemaker leads be banned? Lessons from pacemaker/implantable cardioverter defibrillator interactions.
    Weiss DN; Zilo P; Luceri RM; Habal SM; David IB
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 1):237-9. PubMed ID: 9058859
    [No Abstract]   [Full Text] [Related]  

  • 9. What's the difference between a pacemaker and an implantable cardioverter defibrillator (ICD)?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):8. PubMed ID: 11682906
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recommendations of the Department of Arrhythmia and Clinical Electrophysiology (DAEC) of the Brazilian Cardiology Society on indications for permanent pacemaker implantation, choice of stimulation mode, and indications for automatic cardioverter-defibrillator implantation].
    Sosa EA; de Paola AA; Martinelli M; Costa R; Pimenta J; Lorga AM; Maia IG; d'Avila A; Halperin C
    Arq Bras Cardiol; 1995 Jun; 64(6):579-83. PubMed ID: 8561682
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac device implantation in Fabry disease: A retrospective monocentric study.
    Sené T; Lidove O; Sebbah J; Darondel JM; Picard H; Aaron L; Fain O; Zenone T; Joly D; Charron P; Ziza JM
    Medicine (Baltimore); 2016 Oct; 95(40):e4996. PubMed ID: 27749559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and psychological co-morbidities in children and adolescents with cardiac pacemakers and implanted defibrillators: a cohort study in Eastern Germany.
    Paech C; Ebel V; Wagner F; Stadelmann S; Klein AM; Döhnert M; Dähnert I; Gebauer RA
    Cardiol Young; 2020 Apr; 30(4):549-559. PubMed ID: 32279696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous implantable cardioverter-defibrillator.
    Chang PM; Doshi R; Saxon LA
    Circulation; 2014 Jun; 129(23):e644-6. PubMed ID: 24914020
    [No Abstract]   [Full Text] [Related]  

  • 14. No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy.
    de Greef BT; Hoeijmakers JG; Wolters EE; Smeets HJ; van den Wijngaard A; Merkies IS; Faber CG; Gerrits MM
    PLoS One; 2016; 11(2):e0148316. PubMed ID: 26866599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pacemaker-induced inappropriate implantable cardioverter-defibrillator shock: an unusual case of arrhythmia induction.
    Anderson DR; Fletcher D; Scherschel JA; Easley AR
    Heart Rhythm; 2011 Feb; 8(2):328-30. PubMed ID: 20887806
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
    Weinstock J
    Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy.
    Brambatti M; Mathew R; Strang B; Dean J; Goyal A; Hayward JE; Long L; DeMeis P; Smoke M; Connolly SJ; Morillo CA; Amit G; Capucci A; Healey JS
    Heart Rhythm; 2015 Oct; 12(10):2148-54. PubMed ID: 26049049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
    Maron MS; Xin W; Sims KB; Butler R; Haas TS; Rowin EJ; Desnick RJ; Maron BJ
    Am J Med; 2018 Feb; 131(2):200.e1-200.e8. PubMed ID: 28943383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.
    Masarone D; Duro G; Dellegrottaglie S; Colomba P; Rubino M; Cirillo A; Pisani A; Caiazza M; Elliott PM; Calabrò P; Pacileo G; Limongelli G
    Future Cardiol; 2017 Nov; 13(6):521-527. PubMed ID: 28936893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.